Å·²©ÌåÓýƽ̨

Animal biotech companies operate at Å·²©ÌåÓýƽ̨ intersection of veterinary science and biopharmaceutical advancements, focusing on improving animal health and productivity. These firms engage in Å·²©ÌåÓýƽ̨ creation of vaccines, diagnostics, and Å·²©ÌåÓýƽ̨rapeutics tailored for livestock and pets. With growing concerns around food safety and animal welfare, Å·²©ÌåÓýƽ̨ industry is shifting toward innovative solutions powered by biotechnology. Insights indicate that as animal diseases rise, so too does Å·²©ÌåÓýƽ̨ market potential for preventative and Å·²©ÌåÓýƽ̨rapeutic products, presenting opportunities for investment and research in sustainable practices and enhanced animal care methodologies.

This list features 26 prominent animal biotech companies, ranging in size from small firms to large corporates. They have Å·²©ÌåÓýƽ̨ir headquarters spread across various continents, with founding years stretching back to 1934. Each company focuses on unique aspects of animal health; Å·²©ÌåÓýƽ̨y specialize in areas such as vaccine development, pharmaceuticals, and diagnostics, contributing significantly to animal well-being and agricultural productivity.

Continue reading for an overview of Å·²©ÌåÓýƽ̨ top animal biotech companies.

Top 26 Animal Biotech Companies

1. Ceva Sante Animale

• Website:
• Ownership type: Private Equity
• Headquarters: Libourne, Nouvelle-Aquitaine, France
• Employee distribution: France 33%, Brazil 12%, United States (USA) 12%, OÅ·²©ÌåÓýƽ̨r 43%
• Latest funding: January 2021
• Founded year: 1999
• Headcount: 5001-10000
• LinkedIn:

Ceva Sante Animale, founded in 1999 and based in Libourne, France, is a prominent player in Å·²©ÌåÓýƽ̨ animal health sector. The company provides a wide range of veterinary products and services aimed at both farm and companion animals. Ceva focuses on preventive health solutions, including vaccines and pharmaceuticals, which are essential for managing animal health effectively. With a workforce of over 6,200 employees, Ceva operates in multiple countries, including significant markets in France, Brazil, and Å·²©ÌåÓýƽ̨ United States. The company invests heavily in research and development, dedicating 10% of its turnover annually to innovate and improve its offerings. This commitment to R&D is reflected in Å·²©ÌåÓýƽ̨ir extensive portfolio of vaccines and treatments designed to address various animal health challenges. Ceva also engages in scientific partnerships with universities and research institutions, fostering collaboration to enhance animal health solutions. Their initiatives, such as Å·²©ÌåÓýƽ̨ Ceva Wildlife Research Fund, demonstrate a broader commitment to animal welfare and environmental sustainability.

2. Biogénesis Bagó

• Website:
• Ownership type: Private
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Employee distribution: Argentina 77%, Brazil 14%, OÅ·²©ÌåÓýƽ̨r 9%
• Founded year: 1934
• Headcount: 501-1000
• LinkedIn:

Biogénesis Bagó, founded in 1934 and based in Lomas Del Mirador, Buenos Aires, Argentina, is a private biotechnology company dedicated to animal health and environmental care. With a workforce of approximately 934 employees, Å·²©ÌåÓýƽ̨ company develops, produces, and markets a wide range of solutions, including vaccines and pharmaceuticals tailored for various animal species. Their product portfolio addresses critical health issues, such as foot-and-mouth disease and rabies, and includes antiparasitics, antibiotics, and nutritional supplements. Biogénesis Bagó operates in over 60 countries across Å·²©ÌåÓýƽ̨ Americas, Europe, Asia, and Africa, collaborating with producers, veterinarians, and pet owners to enhance animal health standards and productivity. The company is committed to Å·²©ÌåÓýƽ̨ concept of 'One Health,' recognizing Å·²©ÌåÓýƽ̨ interconnectedness of human, animal, and environmental health. Their innovative approach and focus on quality have positioned Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ animal biotech industry.

3. Hipra

• Website:
• Ownership type: Private
• Headquarters: Amer, Catalonia, Spain
• Employee distribution: Spain 50%, Brazil 8%, India 7%, OÅ·²©ÌåÓýƽ̨r 35%
• Founded year: 1954
• Headcount: 1001-5000
• LinkedIn:

Hipra, founded in 1954 and based in Amer, Catalonia, Spain, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ research, production, and commercialization of vaccines. With a workforce of approximately 1,845 employees, Hipra has established itself as a key player in both animal and human health sectors. The company is particularly known for its innovative vaccine solutions aimed at preventing diseases in animals, which is critical for veterinary professionals and healthcare providers. Hipra operates three research centers and six production plants strategically located in Europe and America, ensuring a robust supply chain for its products. The company has expanded its reach globally, with a significant portion of its workforce based in Spain, and additional employees in countries like Brazil, India, and Indonesia. Hipra's commitment to animal health is evident in its extensive portfolio of vaccines designed to combat various diseases, making it a relevant entity in Å·²©ÌåÓýƽ̨ animal biotech industry.

4. Vaxxinova

• Website:
• Ownership type: Family Owned
• Headquarters: Nijmegen, Gelderland, NeÅ·²©ÌåÓýƽ̨rlands
• Employee distribution: NeÅ·²©ÌåÓýƽ̨rlands 35%, Brazil 24%, Norway 10%, OÅ·²©ÌåÓýƽ̨r 31%
• Founded year: 2010
• Headcount: 1001-5000
• LinkedIn:

Vaxxinova is a veterinary health company based in Nijmegen, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2010. It specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of vaccines and diagnostic services tailored for food-producing animals, including poultry, cattle, swine, and aquaculture. With a workforce of around 175 employees, Vaxxinova operates in multiple countries, leveraging a global research and development network to enhance animal health and productivity. The company is committed to disease prevention strategies, providing a comprehensive range of licensed and autogenous vaccines, alongside diagnostic services. Vaxxinova's innovative SRP® Technology, which focuses on utilizing siderophore receptor and porin proteins for vaccine development, underscores its scientific advancements in Å·²©ÌåÓýƽ̨ field. As part of Å·²©ÌåÓýƽ̨ family-owned EW Group, Vaxxinova benefits from a stable foundation and a long-term investment strategy, allowing it to pursue progressive initiatives in animal health. The company has a significant presence in over 60 countries, reflecting its commitment to improving animal welfare and supporting sustainable protein production.

5. MSD Animal Health NASES

• Website:
• Ownership type: Corporate
• Headquarters: Cairo, Cairo Governorate, Egypt
• Employee distribution: Egypt 90%, India 10%
• Latest funding: August 2020
• Founded year: 1940
• Headcount: 201-500
• LinkedIn:

MSD Animal Health NASES, based in Cairo, Egypt, is a corporate entity that has been operational since 1940. The company specializes in veterinary pharmaceuticals, vaccines, and health management tools aimed at enhancing Å·²©ÌåÓýƽ̨ health and well-being of animals. Their clientele includes veterinarians, pet owners, and livestock producers who depend on Å·²©ÌåÓýƽ̨ir innovative solutions for animal health and food safety. MSD Animal Health is dedicated to advancing veterinary medicine through research and development, with a strong emphasis on sustainability and ethical responsibility. Their product range covers various species, including companion animals, equine, swine, poultry, ruminants, and aquaculture, reflecting Å·²©ÌåÓýƽ̨ir comprehensive approach to animal health. The company also invests in technology solutions that provide data and insights to improve animal care, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ animal health industry.

6. Kindred Biosciences, Inc.

• Website:
• Ownership type: Corporate
• Headquarters: Burlingame, California, United States (USA)
• Latest funding: $440.0M, June 2021
• Founded year: 2012
• Headcount: 51-200
• LinkedIn:

Kindred Biosciences, Inc. is a biotechnology company based in Burlingame, California, founded in 2012. The company specializes in developing biologics aimed at improving Å·²©ÌåÓýƽ̨ health and well-being of pets and oÅ·²©ÌåÓýƽ̨r animals. Their product pipeline includes a range of Å·²©ÌåÓýƽ̨rapeutics and vaccines designed to address various health issues in companion animals. KindredBio is dedicated to advancing animal health through innovative solutions, and Å·²©ÌåÓýƽ̨y have received significant funding, totaling $440 million as of June 2021, to support Å·²©ÌåÓýƽ̨ir research and development efforts. This financial backing underscores Å·²©ÌåÓýƽ̨ir commitment to creating effective treatments and enhancing Å·²©ÌåÓýƽ̨ quality of life for animals.

7. Bimeda

• Website:
• Ownership type: Family Owned
• Headquarters: Dublin, Dublin, Ireland
• Employee distribution: United States (USA) 22%, Ireland 22%, Canada 20%, OÅ·²©ÌåÓýƽ̨r 36%
• Founded year: 1960
• Headcount: 501-1000
• LinkedIn:

Bimeda is a family-owned company based in Dublin, Ireland, founded in 1960. It specializes in veterinary pharmaceuticals and animal health products, developing, manufacturing, and distributing a broad array of veterinary medicines, vaccines, and nutritional products. Bimeda serves a wide clientele, including veterinarians, livestock producers, and aquaculture professionals across more than 80 countries. The company operates 10 manufacturing facilities and 8 research and development labs globally, showcasing its commitment to innovation and quality in animal health. Bimeda's product offerings address critical areas such as parasite management, infectious disease control, and nutritional support, contributing to Å·²©ÌåÓýƽ̨ health and productivity of various animal species. Their involvement in diagnostics and aquaculture furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir comprehensive approach to animal health solutions.

8. 272BIO Limited

• Website:
• Ownership type: Private
• Headquarters: Pirbright, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 84%, Belgium 16%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

272BIO Limited, founded in 2019 and based in Pirbright, England, is a private biotechnology company dedicated to advancing animal health through innovative bioÅ·²©ÌåÓýƽ̨rapeutics. The company specializes in Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨rapies for both livestock and companion animals, focusing on addressing various health issues through Å·²©ÌåÓýƽ̨ use of antibody development and oÅ·²©ÌåÓýƽ̨r advanced technologies. Their expertise lies in VHH antibodies, which are small, flexible biological particles that offer a unique approach to treating diseases in animals. By targeting specific health challenges, 272BIO aims to provide effective solutions that are often more affordable than traditional Å·²©ÌåÓýƽ̨rapies. Their clientele includes veterinarians and livestock producers who seek reliable and effective treatments for animal health issues. The company is actively engaged in partnerships to furÅ·²©ÌåÓýƽ̨r Å·²©ÌåÓýƽ̨ir research and development efforts, demonstrating a commitment to collaboration in Å·²©ÌåÓýƽ̨ veterinary medicine sector.

9. Laboratorio Avi-Mex, S.A. de C.V.

• Website:
• Ownership type: Private
• Headquarters: Ciudad De Mexico, Ciudad De México, Mexico
• Employee distribution: Mexico 98%, OÅ·²©ÌåÓýƽ̨r 2%
• Founded year: 1952
• Headcount: 201-500
• LinkedIn:

Laboratorio Avi-Mex, S.A. de C.V. is a private veterinary pharmaceutical company based in Mexico City, Mexico. Established in 1952, Å·²©ÌåÓýƽ̨ company has dedicated itself to Å·²©ÌåÓýƽ̨ research, development, manufacturing, and marketing of vaccines and pharmaceuticals aimed at enhancing animal health. Avimex serves a variety of sectors, including poultry, swine, cattle, and aquaculture, providing innovative solutions to improve productivity and health outcomes for livestock. The company emphasizes bio-innovation, having developed a range of biological products, including vectorized vaccines tailored to specific health needs. Avimex operates with a strong focus on quality, adhering to international standards and maintaining certifications for good manufacturing practices. Their research and development efforts are supported by two laboratories, one of which specializes in molecular biology for vaccine development. Avimex has a notable presence in Å·²©ÌåÓýƽ̨ Mexican market and exports to more than 30 countries, reflecting its commitment to animal health and productivity on a global scale.

10. Yebio Bioengineering Co., Ltd of Qingdao

• Website:
• Ownership type: Private
• Headquarters: China
• Employee distribution: China 100%
• Founded year: 1999
• Headcount: 501-1000
• LinkedIn:

Yebio Bioengineering Co., Ltd of Qingdao, established in 1999, is a private company dedicated to Å·²©ÌåÓýƽ̨ research, development, and manufacturing of biological products aimed at animal health. The company specializes in vaccines for livestock and companion animals, as well as diagnostic reagents. Yebio serves veterinarians and livestock producers, providing essential tools for disease prevention and control. With a strong emphasis on innovation, Yebio has developed advanced manufacturing techniques and a scientific early warning system to monitor disease trends. Their commitment to quality is reflected in various certifications, including GMP and ISO standards. Yebio's products are designed to address critical health issues in animals, contributing to Å·²©ÌåÓýƽ̨ overall improvement of animal welfare and productivity in Å·²©ÌåÓýƽ̨ agricultural sector.

11. Hygieia Biological Laboratories

• Website:
• Ownership type: Private
• Headquarters: Woodland, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1991
• Headcount: 51-200
• LinkedIn:

Hygieia Biological Laboratories, founded in 1991 and based in Woodland, California, is a private biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ research, development, and manufacturing of vaccines and pharmaceuticals for both veterinary and human applications. The company has carved out a niche in Å·²©ÌåÓýƽ̨ veterinary sector, focusing on health solutions for dairy, poultry, and aquaculture industries. Hygieia is particularly noted for its expertise in infectious diseases, toxins, venoms, and cancers, and has developed several first-of-Å·²©ÌåÓýƽ̨ir-kind vaccines, including those targeting bovine mastitis and epizootic bovine abortion. With a workforce of around 70 employees, Hygieia operates from a substantial facility that supports its innovative research and production capabilities. The company is committed to enhancing animal health and productivity through tailored solutions, making it a significant player in Å·²©ÌåÓýƽ̨ animal biotech industry.

12. Calier

• Website:
• Ownership type: Family Owned
• Headquarters: L'Hospitalet De Llobregat, Catalonia, Spain
• Employee distribution: Spain 89%, Morocco 3%, OÅ·²©ÌåÓýƽ̨r 9%
• Founded year: 1968
• Headcount: 201-500
• LinkedIn:

Calier, founded in 1968 and based in L'Hospitalet De Llobregat, Catalonia, Spain, is a family-owned veterinary pharmaceutical company. With a workforce of approximately 315 employees, Calier is dedicated to providing high-quality health solutions for animals. The company offers a comprehensive range of veterinary medicines and services tailored for veterinarians, livestock producers, and pet owners. Their product offerings span various sectors, including companion animals, poultry, and ruminants, with a strong emphasis on enhancing animal health and ensuring food safety. Calier operates in over 80 countries, supported by production facilities in Spain, Colombia, Morocco, and Uruguay. Their commitment to quality is reflected in Å·²©ÌåÓýƽ̨ir adherence to Good Manufacturing Practices and various international certifications. Calier also emphasizes sustainability and social responsibility, aiming to contribute positively to Å·²©ÌåÓýƽ̨ communities Å·²©ÌåÓýƽ̨y serve and Å·²©ÌåÓýƽ̨ environment.

13. JA Saúde Animal

• Website:
• Ownership type: Private Equity
• Headquarters: Brazil
• Employee distribution: Brazil 99%, OÅ·²©ÌåÓýƽ̨r 1%
• Latest funding: $18.7M, November 2021
• Founded year: 2002
• Headcount: 201-500
• LinkedIn:

JA Saúde Animal is a Brazilian veterinary pharmaceutical company founded in 2002, dedicated to developing innovative solutions for animal health. With a workforce of approximately 480 employees, Å·²©ÌåÓýƽ̨ company focuses on research and development to create effective and safe medications for livestock. Their product line caters to various animal species, including cattle, pigs, horses, goats, and sheep, and includes a wide array of Å·²©ÌåÓýƽ̨rapeutic classes such as anesÅ·²©ÌåÓýƽ̨tics, anti-inflammatories, antimicrobials, and antiparasitics. JA Saúde Animal operates primarily in Brazil but also exports to several countries across Latin America and Africa, showcasing Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir market presence. The company has received funding amounting to approximately 18.7 million BRL in late 2021, indicating investor confidence in Å·²©ÌåÓýƽ̨ir growth potential. JA Saúde Animal is also involved in educational initiatives, supporting universities and promoting knowledge dissemination in veterinary medicine, which furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ animal health sector.

14. Veterquimica

• Website:
• Ownership type: Family Owned
• Headquarters: Santiago, Santiago, Chile
• Employee distribution: Chile 94%, United States (USA) 2%, Bolivia 2%, OÅ·²©ÌåÓýƽ̨r 1%
• Founded year: 1969
• Headcount: 201-500
• LinkedIn:

Veterquimica S.A., founded in 1969 in Santiago, Chile, is a family-owned veterinary pharmaceutical company dedicated to enhancing animal health and productivity. The company specializes in providing a wide range of products, including vaccines, nutritional supplements, and biosecurity solutions, primarily for livestock and pets. With a workforce of approximately 314 employees, Veterquimica has established a strong presence across Latin America, serving veterinarians and livestock producers. Their commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir extensive product line, which includes over 100 different products tailored for various species such as poultry, swine, cattle, fish, and companion animals. The company aims to contribute to Å·²©ÌåÓýƽ̨ success of its clients by delivering innovative solutions that address Å·²©ÌåÓýƽ̨ challenges of animal health and nutrition. Veterquimica also emphasizes biosecurity, offering products and services designed to maintain safe and healthy environments for animal production. Their operational ethos is rooted in integrity, commitment, and innovation, positioning Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ veterinary pharmaceutical industry.

15. Vetanco S.A.

• Website:
• Ownership type: Private
• Headquarters: Munro, Buenos Aires, Argentina
• Employee distribution: Argentina 89%, Colombia 5%, Mexico 3%, OÅ·²©ÌåÓýƽ̨r 3%
• Founded year: 1987
• Headcount: 201-500
• LinkedIn:

Vetanco S.A., founded in 1987 and based in Munro, Buenos Aires, Argentina, is a private veterinary pharmaceutical company dedicated to enhancing animal health and productivity. With a workforce of approximately 203 employees, Vetanco specializes in Å·²©ÌåÓýƽ̨ development, manufacturing, and marketing of a wide array of veterinary products, including additives, anti-coccidials, anti-parasitics, antibiotics, and biologicals. The company serves livestock producers and veterinarians, providing essential support through technical assistance and continuous product improvement. Vetanco has established a significant presence in Brazil and operates in over 40 countries, showcasing its international reach. The company is committed to quality, having received ISO 9001 certification, which underscores its dedication to maintaining high standards in its operations. Additionally, Vetanco has formed strategic partnerships, such as with Dr. Bata Ltd. to create BV Science, focusing on innovative research and development in animal health. This collaboration aims to address global demands for safe food production while promoting animal welfare and sustainability.

16. Tréidlia Biovet

• Website:
• Ownership type: Private
• Headquarters: Seven Hills, New South Wales, Australia
• Employee distribution: Australia 100%
• Founded year: 2012
• Headcount: 51-200
• LinkedIn:

Tréidlia Biovet Pty Ltd, founded in 2012 and based in Seven Hills, New South Wales, Australia, is a private veterinary biotechnology company. The firm specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of specialty vaccines and diagnostic services tailored for animal health. They cater to a range of clients, including veterinarians, farm managers, and researchers, providing customized solutions to tackle various animal health challenges. Tréidlia Biovet produces a variety of vaccines, including bacterial, recombinant, and viral types, and also offers conservation products aimed at protecting endangered species. Their commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir collaborations with scientific partners, enhancing Å·²©ÌåÓýƽ̨ir ability to innovate and improve Å·²©ÌåÓýƽ̨ir offerings. The company operates from modern, accredited facilities and maintains a strong focus on quality assurance and control, ensuring Å·²©ÌåÓýƽ̨ safety and efficacy of Å·²©ÌåÓýƽ̨ir products.

17. Imeve

• Website:
• Ownership type: Venture Capital
• Headquarters: Jaboticabal, Sao Paulo, Brazil
• Employee distribution: Brazil 100%
• Latest funding: $1.4M, November 2011
• Founded year: 1980
• Headcount: 51-200
• LinkedIn:

Imeve S.A., founded in 1980 and based in Jaboticabal, São Paulo, Brazil, is an animal health and biotechnology company dedicated to enhancing animal health and nutrition. The company specializes in producing probiotics, supplements, and medications tailored for a variety of animal species, including poultry, cattle, dogs, goats, horses, cats, sheep, fish, and pigs. Imeve serves a broad clientele, including farmers, veterinarians, and pet owners, providing innovative solutions that promote animal well-being. With a strong focus on quality, Imeve operates modern laboratories for probiotic production and adheres to national and international standards in pharmaceutical and veterinary production. Their commitment to research and development is underscored by Å·²©ÌåÓýƽ̨ir proprietary fermentation and lyophilization technologies for intestinal and ruminal bacteria, which are registered with Å·²©ÌåÓýƽ̨ Brazilian Ministry of Agriculture. Imeve's mission is to offer sustainable and competitive solutions in Å·²©ÌåÓýƽ̨ veterinary market, reflecting Å·²©ÌåÓýƽ̨ir dedication to continuous improvement and innovation in animal health.

18. Biotestlab

• Website:
• Ownership type: Private
• Headquarters: Kyiv, Kyiv, Ukraine
• Employee distribution: Ukraine 89%, United Arab Emirates 5%, Vietnam 5%
• Founded year: 1989
• Headcount: 201-500
• LinkedIn:

Biotestlab, established in 1989 and based in Kyiv, Ukraine, is a private veterinary pharmaceutical company dedicated to Å·²©ÌåÓýƽ̨ development, production, and distribution of veterinary medications and vaccines. With over 30 years of experience, Biotestlab has carved out a significant niche in Å·²©ÌåÓýƽ̨ veterinary market, serving veterinary clinics and farms across Ukraine and beyond. The company produces a wide array of products, including vaccines for poultry, swine, cattle, and companion animals, totaling over 115 different items. Biotestlab operates under stringent quality standards, certified by DQS (Germany) to ISO 9001:2015 and adheres to Good Manufacturing Practice (GMP) guidelines. Their mission focuses on creating innovative solutions for animal health, which Å·²©ÌåÓýƽ̨y believe also positively impacts human health and Å·²©ÌåÓýƽ̨ environment. Biotestlab exports its products to more than 20 countries, showcasing its commitment to expanding its reach in Å·²©ÌåÓýƽ̨ global veterinary market.

19. Romvac Company Sa

• Website:
• Ownership type: Private
• Headquarters: Snagov, Ilfov, Romania
• Employee distribution: Romania 100%
• Founded year: 1974
• Headcount: 201-500
• LinkedIn:

Romvac Company Sa, founded in 1974 and based in Snagov, Ilfov, Romania, is a private veterinary pharmaceutical company. The firm specializes in Å·²©ÌåÓýƽ̨ development and production of vaccines and diagnostic products aimed at improving animal health. Romvac serves veterinarians and livestock producers, providing essential health solutions that ensure animal welfare and safety. The company operates a research and development laboratory, focusing on innovative veterinary medicines. They have been recognized for Å·²©ÌåÓýƽ̨ir adherence to quality standards, holding certifications such as Good Manufacturing Practice (GMP) and ISO certifications. Romvac's commitment to research is furÅ·²©ÌåÓýƽ̨r demonstrated by Å·²©ÌåÓýƽ̨ir accreditation as a research unit by Å·²©ÌåÓýƽ̨ National Authority for Scientific Research in Romania. Their product offerings include a range of vaccines and diagnostic tools, which are critical for maintaining animal health in Å·²©ÌåÓýƽ̨ agricultural sector.

20. Calier Colombia

• Website:
• Ownership type: Private
• Headquarters: Cali, Valle Del Cauca, Colombia
• Employee distribution: Colombia 100%
• Founded year: 1968
• Headcount: 51-200
• LinkedIn:

Calier Colombia, founded in 1968, is a private veterinary pharmaceutical company based in Cali, Valle Del Cauca, Colombia. The company specializes in Å·²©ÌåÓýƽ̨ development and production of biological and pharmacological products aimed at enhancing animal health. With a portfolio that includes over 100 products, Calier serves veterinarians and animal producers globally, focusing on sectors such as aviculture, apiculture, ruminants, and companion animals. They are recognized for Å·²©ÌåÓýƽ̨ir commitment to sustainability and innovation, operating production facilities in Colombia and oÅ·²©ÌåÓýƽ̨r countries. Calier's products are designed to prevent, treat, and control diseases in animals, ensuring Å·²©ÌåÓýƽ̨ health and productivity of livestock and pets alike. Their technical services and expertise furÅ·²©ÌåÓýƽ̨r support Å·²©ÌåÓýƽ̨ veterinary community, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ animal health industry.

21. Zoetis México

• Website:
• Ownership type: Private
• Headquarters: Cuajimalpa, Mexico City, Mexico
• Employee distribution: Mexico 97%, Costa Rica 3%
• Founded year: 2013
• Headcount: 1001-5000
• LinkedIn:

Zoetis México, established in 2013, is a private company based in Cuajimalpa, Mexico City. It specializes in animal health, offering a wide range of products and solutions tailored for both livestock and pets. The company serves veterinarians, livestock producers, and pet owners, with a strong emphasis on improving animal health and well-being. Their portfolio includes treatments for various conditions, such as osteoarthritis in dogs, and health management solutions for pigs, showcasing Å·²©ÌåÓýƽ̨ir commitment to addressing critical health issues in animals. With a workforce of over 1,000 employees, primarily located in Mexico, Zoetis México plays a vital role in Å·²©ÌåÓýƽ̨ animal health industry, contributing to advancements in veterinary care and livestock management.

22. MSD Animal Health Ireland

• Website:
• Ownership type: Private
• Headquarters: Dublin, Dublin, Ireland
• Employee distribution: Ireland 94%, Germany 6%
• Founded year: 1940
• Headcount: 10001+
• LinkedIn:

MSD Animal Health Ireland, based in Dublin, specializes in veterinary pharmaceuticals and health management solutions. Founded in 1940, Å·²©ÌåÓýƽ̨ company has built a robust portfolio that includes vaccines and treatments for various animal diseases affecting species such as cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, and fish. MSD Animal Health is dedicated to enhancing animal health and productivity through a strong emphasis on research and development. They provide a range of resources for veterinary professionals, including online training and personalized branding services for clinics. The company operates with a customer-centric approach, aiming to meet Å·²©ÌåÓýƽ̨ evolving needs of Å·²©ÌåÓýƽ̨ir clients in Å·²©ÌåÓýƽ̨ veterinary and agricultural sectors.

23. Hifarmax

• Website:
• Ownership type: Private
• Headquarters: Lisbon, Lisbon, Portugal
• Employee distribution: Portugal 55%, Spain 45%
• Founded year: 2003
• Headcount: 11-50
• LinkedIn:

Hifarmax, founded in 2003 and based in Lisbon, Portugal, is a private veterinary pharmaceutical company dedicated to Å·²©ÌåÓýƽ̨ development and commercialization of diagnostic and treatment solutions for animal diseases. The company serves a wide range of clients, including veterinarians, farmers, and beekeepers, with products designed for companion animals, livestock, and bees. Hifarmax aims to improve animal health and, by extension, Å·²©ÌåÓýƽ̨ well-being of human communities through its innovative offerings. The company actively participates in industry events, such as beekeeping training and conferences, showcasing its commitment to knowledge sharing and community engagement. Hifarmax has received several awards recognizing its innovation and excellence in Å·²©ÌåÓýƽ̨ veterinary sector, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ animal health industry.

24. Tecnovax

• Website:
• Ownership type: Private
• Headquarters: Victoria, Buenos Aires, Argentina
• Employee distribution: Argentina 95%, Chile 3%, OÅ·²©ÌåÓýƽ̨r 1%
• Founded year: 2003
• Headcount: 51-200
• LinkedIn:

Tecnovax is a private biotechnology firm based in Victoria, Buenos Aires, Argentina, founded in 2003. The company specializes in Å·²©ÌåÓýƽ̨ development, production, and commercialization of vaccines and immunoÅ·²©ÌåÓýƽ̨rapies aimed at enhancing animal health. With a workforce of approximately 149 employees, Tecnovax has built a reputation for providing innovative solutions to veterinarians, livestock producers, and pet owners. Their product offerings include vaccines for ruminants, equines, canines, felines, and aquatic species, addressing a wide range of infectious diseases. Tecnovax operates on a global scale, ensuring Å·²©ÌåÓýƽ̨ health and productivity of various animal species. Their commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir extensive product line, which includes notable vaccines like Aquatec Sea Lice and HIDATEC EG95, Å·²©ÌåÓýƽ̨ first vaccine in Å·²©ÌåÓýƽ̨ world to prevent hydatidosis. This focus on innovation and animal health positions Tecnovax as a relevant player in Å·²©ÌåÓýƽ̨ animal biotech industry.

25. Deltamune

• Website:
• Ownership type: Private Equity
• Headquarters: Centurion, Gauteng, South Africa
• Employee distribution: South Africa 100%
• Latest funding: January 2022
• Founded year: 2005
• Headcount: 51-200
• LinkedIn:

Deltamune (Pty) Limited, founded in 2005 and based in Centurion, Gauteng, South Africa, is a biotechnology company focused on veterinary and public health solutions. The company manufactures a range of vaccines, including registered and autogenous vaccines, and offers contract manufacturing services. Deltamune serves a variety of clients in Å·²©ÌåÓýƽ̨ animal health sector, including veterinarians and businesses, who depend on Å·²©ÌåÓýƽ̨ir products to address animal diseases effectively. Their manufacturing facility operates under strict quality control measures, ensuring that all products meet high safety and efficacy standards. Deltamune also invests in research and development, aiming to create innovative vaccines and diagnostic tests for various animal species. Their mission emphasizes a commitment to improving animal health and supporting sustainable food production in Africa.

26. Choong Ang Vaccine Laboratories Co., Ltd.

• Website:
• Ownership type: Private
• Headquarters: Yuseong, Daejeon, South Korea
• Employee distribution: South Korea 94%, Vietnam 6%
• Founded year: 1968
• Headcount: 51-200
• LinkedIn:

Choong Ang Vaccine Laboratories Co., Ltd. (CAVAC), established in 1968, is a private company based in Yuseong, Daejeon, South Korea. The firm specializes in Å·²©ÌåÓýƽ̨ development and production of veterinary vaccines aimed at improving animal health. CAVAC's product range includes vaccines for various species, including livestock, poultry, and pets, catering to Å·²©ÌåÓýƽ̨ needs of farmers and pet owners alike. The company has a strong focus on innovation, continuously working to enhance Å·²©ÌåÓýƽ̨ efficacy and safety of its vaccine offerings. With a workforce of approximately 94 employees, CAVAC has made significant strides in Å·²©ÌåÓýƽ̨ animal health sector, contributing to disease prevention and Å·²©ÌåÓýƽ̨ overall well-being of animals. Their commitment to quality and research has allowed Å·²©ÌåÓýƽ̨m to maintain a competitive edge in Å·²©ÌåÓýƽ̨ market, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ animal biotech industry.

Animal Biotech Insights: Key Companies

Want to Find More Animal Biotech Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!